BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 30392207)

  • 1. [A family with Allan-Herndon-Dudley syndrome due to SLC16A2 gene mutation].
    Tang YL; Peng J; Xiong J; Pang N; Wu LW; Yang HY; Kessi M; Yin F
    Zhonghua Er Ke Za Zhi; 2018 Nov; 56(11):829-834. PubMed ID: 30392207
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and genetic features of five patients with Allan-Herndon-Dudley syndrome].
    Wang J; Zhang Q; Bao X; Chen Y; Yu S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Aug; 35(4):484-488. PubMed ID: 30098239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the phenotypic spectrum of Allan-Herndon-Dudley syndrome in patients with SLC16A2 mutations.
    Remerand G; Boespflug-Tanguy O; Tonduti D; Touraine R; Rodriguez D; Curie A; Perreton N; Des Portes V; Sarret C;
    Dev Med Child Neurol; 2019 Dec; 61(12):1439-1447. PubMed ID: 31410843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelination Delay and Allan-Herndon-Dudley Syndrome Caused by a Novel Mutation in the SLC16A2 Gene.
    La Piana R; Vanasse M; Brais B; Bernard G
    J Child Neurol; 2015 Sep; 30(10):1371-4. PubMed ID: 25380603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed myelination is not a constant feature of Allan-Herndon-Dudley syndrome: report of a new case and review of the literature.
    Azzolini S; Nosadini M; Balzarin M; Sartori S; Suppiej A; Mardari R; Greggio NA; Toldo I
    Brain Dev; 2014 Sep; 36(8):716-20. PubMed ID: 24268987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel variant in SLC16A2 associated with typical Allan-Herndon-Dudley syndrome: a case report.
    Chen X; Liu L; Zeng C
    BMC Pediatr; 2022 Apr; 22(1):180. PubMed ID: 35382784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent Esotropia in 4 Patients With Allan-Herndon-Dudley Syndrome.
    Swiston CJ; Nash DL
    J Child Neurol; 2018 Jul; 33(8):525-527. PubMed ID: 29714107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allan-Herndon-Dudley syndrome (AHDS) caused by a novel SLC16A2 gene mutation showing severe neurologic features and unexpectedly low TRH-stimulated serum TSH.
    Boccone L; Mariotti S; Dessì V; Pruna D; Meloni A; Loudianos G
    Eur J Med Genet; 2010; 53(6):392-5. PubMed ID: 20713192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allan-Herndon-Dudley syndrome (AHDS) in two consecutive generations caused by a missense MCT8 gene mutation. Phenotypic variability with the presence of normal serum T3 levels.
    Boccone L; Dessì V; Meloni A; Loudianos G
    Eur J Med Genet; 2013 Apr; 56(4):207-10. PubMed ID: 23419639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable Clinical Characteristics and Molecular Spectrum of Patients with Syndromes of Reduced Sensitivity to Thyroid Hormone: Genetic Defects in the THRB and SLC16A2 Genes.
    Choi JH; Cho JH; Kim JH; Yoo EG; Kim GH; Yoo HW
    Horm Res Paediatr; 2018; 90(5):283-290. PubMed ID: 30497070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 7-month-old male with Allan-Herndon-Dudley syndrome and the power of T3.
    Langley KG; Trau S; Bean LJ; Narravula A; Schrier Vergano SA
    Am J Med Genet A; 2015 May; 167A(5):1117-20. PubMed ID: 25755011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The importance of thyroid hormone transporters].
    Braun D
    Nuklearmedizin; 2015; 54(3):77-81. PubMed ID: 26105714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical course and images of four familial cases of Allan-Herndon-Dudley syndrome with a novel monocarboxylate transporter 8 gene mutation.
    Kobayashi S; Onuma A; Inui T; Wakusawa K; Tanaka S; Shimojima K; Yamamoto T; Haginoya K
    Pediatr Neurol; 2014 Sep; 51(3):414-6. PubMed ID: 25160547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Molecular Characteristics of SLC16A2 (MCT8) Mutations in Three Families with the Allan-Herndon-Dudley Syndrome.
    Novara F; Groeneweg S; Freri E; Estienne M; Reho P; Matricardi S; Castellotti B; Visser WE; Zuffardi O; Visser TJ
    Hum Mutat; 2017 Mar; 38(3):260-264. PubMed ID: 27805744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychomotor retardation caused by a defective thyroid hormone transporter: report of two families with different MCT8 mutations.
    Anık A; Kersseboom S; Demir K; Catlı G; Yiş U; Böber E; van Mullem A; van Herebeek RE; Hız S; Abacı A; Visser TJ
    Horm Res Paediatr; 2014; 82(4):261-71. PubMed ID: 25247785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe neurological abnormalities in a young boy with impaired thyroid hormone sensitivity due to a novel mutation in the MCT8 gene.
    Rego T; Lado CG; Rodríguez PC; Santos FS; Angueira FB; Castro-Feijóo L; Conde JB; Castro-Gago M
    Hormones (Athens); 2017 Apr; 16(2):194-199. PubMed ID: 28742507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further Insights into the Allan-Herndon-Dudley Syndrome: Clinical and Functional Characterization of a Novel MCT8 Mutation.
    Armour CM; Kersseboom S; Yoon G; Visser TJ
    PLoS One; 2015; 10(10):e0139343. PubMed ID: 26426690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel frameshift mutation in Allan-Herndon-Dudley syndrome.
    Liu Z; Zhao S; Chen J; Ma L; Shi Q; Zhou Y
    Int J Legal Med; 2022 Jul; 136(4):1181-1187. PubMed ID: 35391604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Exome sequencing revealed Allan-Herndon-Dudley syndrome underlying multiple disabilities].
    Arvio M; Philips AK; Ahvenainen M; Somer M; Kalscheuer V; Järvelä I
    Duodecim; 2014; 130(21):2202-5. PubMed ID: 25582014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and endocrine features of two Allan-Herndon-Dudley syndrome patients with monocarboxylate transporter 8 mutations.
    Kim JH; Kim YM; Yum MS; Choi JH; Lee BH; Kim GH; Yoo HW
    Horm Res Paediatr; 2015; 83(4):288-92. PubMed ID: 25896225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.